• 18466 Citations
  • 69 Scopus h-Index
1976 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1985 2019

Filter
Comment/debate
2014

Erratum to: Phase I study of PF-04691502, a small-molecule, oral, dual inhibitor of PI3K and mTOR, in patients with advanced cancer (Investigational New Drugs DOI: 10.1007/s10637-013-0062-5)

Britten, C. D., Adjei, A., Millham, R., Houk, B. E., Borzillo, G., Pierce, K., Wainberg, Z. A. & LoRusso, P. M., Jan 1 2014, In : Investigational New Drugs. 32, 3, 1 p.

Research output: Contribution to journalComment/debate

Investigational Drugs
Phosphatidylinositol 3-Kinases
Neoplasms
2-amino-8-(4-(2-hydroxyethoxy)cyclohexyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido(2,3-d)pyrimidin-7(8H)-one
2002

"Targeted" therapies for non-small-cell lung cancer

Adjei, A., Jan 1 2002, In : Clinical Lung Cancer. 4, 2, 1 p.

Research output: Contribution to journalComment/debate

Non-Small Cell Lung Carcinoma
Therapeutics